Clinical Trial Update: First in Man Study of Safety, Tolerability and PK Profile of RBP-7000 [Phase 1]

View source ↗

Summary

First-in-man Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of RBP-7000 in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• RBP-7000

Snippet

Sponsor: Indivior Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED